FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nadar Hanna

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Living Beings

Activities & Behaviors

SEER Program

Co-author Network

Publications

TOP 3
V V Chirikov; Nadar N Hanna; C. Daniel Mullins; B Seal; I M Breunig; Fadia T. Shaya
Multidisciplinary physician care and mortality in hepatocellular carcinoma.
Z Zheng; K Bikov; Nadar N Hanna; Eberechukwu Onukwugha; B Seal; C. Daniel Mullins
Association between overall incremental cost and survival benefit of second line chemotherapy/biologics treatment among elderly medicare metastatic colon cancer patients.
Fadia T. Shaya; I M Breunig; V V Chirikov; C. Daniel Mullins; B Seal; Nadar N Hanna
Treatment modalities for hepatocellular carcinoma: cumulative expenditures and survival in seer-medicare.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nadar Hanna (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: V V Chirikov; Nadar N Hanna; C. Daniel Mullins; B Seal; I M Breunig; Fadia T. Shaya
Multidisciplinary physician care and mortality in hepatocellular carcinoma.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2013;16(3):A185.
2013: Z Zheng; K Bikov; Nadar N Hanna; Eberechukwu Onukwugha; B Seal; C. Daniel Mullins
Association between overall incremental cost and survival benefit of second line chemotherapy/biologics treatment among elderly medicare metastatic colon cancer patients.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2013;16(3):A139.
2013: Fadia T. Shaya; I M Breunig; V V Chirikov; C. Daniel Mullins; B Seal; Nadar N Hanna
Treatment modalities for hepatocellular carcinoma: cumulative expenditures and survival in seer-medicare.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2013;16(3):A134.
2013: Z Zheng; Eberechukwu Onukwugha; K Bikov; Nadar N Hanna; C. Daniel Mullins
Hospital center effect for laparoscopic colectomy among elderly stage I-iii colon cancer patients.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2013;16(3):A130.
2013: I M Breunig; V V Chirikov; Nadar N Hanna; B Seal; Fadia T. Shaya; C. Daniel Mullins
The use of transarterial chemoembolization for treating hepatocellular carcinoma in the seer-medicare population.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2013;16(3):A1-2.
2013: Keli M Turner; Yue Zhu; Rebecca A Switzer; Latoya M Taylor; Nadar N Hanna; Ajay Jain; Susan Kesmodel; H Richard Alexander
Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer.
Annals of surgical oncology 2013;20(4):1068-73.
2013: Yue Zhu; Cherif Boutros; Nadar N Hanna; H Richard Alexander
Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases.
Journal of gastrointestinal oncology 2013;4(1):62-71.
2012: Susannah Yovino; Richard D Schulick; Christopher L Wolfgang; Richard B Alexander; Olga Goloubeva; Nadar N Hanna; JOSEPH HERMAN; Daniel Laheru; Bert W Maidment; Naimish B Pandya; William F Regine
Analysis of local control in patients receiving IMRT for resected pancreatic cancers.
International journal of radiation oncology, biology, physics 2012;83(3):916-20.
2012: C. Daniel Mullins; Eberechukwu Onukwugha; Naimish B Pandya; Fei-Yuan Hsiao; Nadar N Hanna
Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
Cancer 2012;118(12):3173-81.
2012: Kenneth J Chang; Nadar N Hanna; Harlan Pinto; Tony Reid; Neil Senzer; Amitabh Chak; Stephen Swisher; Roy Soetikno
Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer.
Gastrointestinal endoscopy 2012;75(6):1139-46.e2.
2012: Nadar N Hanna; L Appelbaum; A Czerniak; A Hubert; F M Konikoff; Y Kopelman; G Leichtmann; P Ohana; A Hochberg
Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer.
Cancer gene therapy 2012;19(6):374-81.
2012: Renty B Franklin; Nadar N Hanna; Leslie A Johnson; Bernard A Levy; Jing Zou; Omar Bagasra; Mohamed M Desouki; Leslie C Costello
ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer.
Journal of gastrointestinal cancer 2012;43(2):249-57.
2012: Bertrand Janne d'Othée; Matthew S Johnson; Steven J Cohen; Jean-Francois H Geschwind; Nadar N Hanna; Andrew S Kennedy; Robert J Lewandowski; Ravi Murthy; Constantinos T Sofocleous; Michael C Soulen; Jean-Nicolas Vauthey; Alan P Venook; Stephen T Kee
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel.
Journal of vascular and interventional radiology : JVIR 2012;23(2):153-63.
2012: J Randolph Hecht; Milind Javle; Milan Kovacevic; John Nemunaitis; Mitchell Posner; Anthony Reid; Alexander Rosemurgy; Neil Senzer; Gretta Blatner; Marcia Canto; Amitabh Chak; Kenneth J Chang; Theodore Chung; Richard Erickson; James Farrell; Nadar N Hanna; Irving Waxman; Mark Thornton
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study.
Gastrointestinal endoscopy 2012;75(2):332-8.
2012: Nadar N Hanna; Diane McNally; Kaloyan A Bikov; Mehul Dalal; Nneka C Onwudiwe; C. Daniel Mullins
Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer.
The oncologist 2012;17(9):1191-7.
2012: Geng Zhang; Curtis Lacy; Dong H Lee; Anirban Maitra; Thomas Ried; Aaron Schetter; Harris G Yfantis; H Richard Alexander; Naotake Funamizu; Jochen Gaedcke; B Michael Ghadimi; Nadar N Hanna; Raffit Hassan; Peijun He; S Perwez Hussain
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.
PloS one 2012;7(2):e31507.
2012: Nadar N Hanna; V D Hsu; Michael A Choti; Amy J Davidoff; Eberechukwu Onukwugha; Ilene Harris Zuckerman; C. Daniel Mullins
Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2012;14(1):48-55.
2011: Fei-Yuan Hsiao; C. Daniel Mullins; Eberechukwu Onukwugha; Naimish B Pandya; Nadar N Hanna
Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
Journal of the American Geriatrics Society 2011;59(9):1717-23.
2011: Leslie C Costello; Mohamed M Desouki; Omar Bagasra; Nadar N Hanna; Leslie A Johnson; Bernard A Levy; Jing Zou; Renty B Franklin
Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.
Cancer biology & therapy 2011;12(4):297-303.
2011: Nadar N Hanna; Emily Bellavance; Timothy J Keay
Palliative surgical oncology.
The Surgical clinics of North America 2011;91(2):343-53, viii.
2011: Patricia L Turner; Aaron G Ilano; Yue Zhu; Steven B Johnson; Nadar N Hanna
ACS-NSQIP criteria are associated with APACHE severity and outcomes in critically ill surgical patients.
Journal of the American College of Surgeons 2011;212(3):287-94.
2011: Susannah Yovino; Matthew Poppe; Salma Jabbour; Vera David; Michael C Garofalo; Naimish B Pandya; Richard B Alexander; Nadar N Hanna; William F Regine
Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers.
International journal of radiation oncology, biology, physics 2011;79(1):158-62.
2009: Amy J Davidoff; Thomas Rapp; Eberechukwu Onukwugha; Ilene Harris Zuckerman; Nadar N Hanna; Naimish B Pandya; C. Daniel Mullins
Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.
Medical care 2009;47(12):1229-36.
2008: Patrick E Young; Scott Oosterveen; Nadar N Hanna; Peter E Darwin
Presacral schwannoma diagnosed by EUS-guided FNA.
Gastrointestinal endoscopy 2008;67(2):383-5.
2007: William F Regine; Nadar N Hanna; Michael C Garofalo; Austin Doyle; Susanne Arnold; Ritesh Kataria; Jacqueline Sims; Ming Tan; Mohammed Mohiuddin
Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm.
International journal of radiation oncology, biology, physics 2007;68(1):172-7.
2007: Summer L Nugent; Steven C Cunningham; Borislav Alexiev; Emily Bellavance; John C Papadimitriou; Nadar N Hanna
Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity.
Diagnostic pathology 2007;2():43.
2007: H Richard Alexander; Nadar N Hanna; James F Pingpank
Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma.
Cancer treatment and research 2007;134():343-55.
2007: JESUS ESQUIVEL; R Sticca; P Sugarbaker; E Levine; T D Yan; Richard B Alexander; D Baratti; D Bartlett; R Barone; P Barrios; S Bieligk; P Bretcha-Boix; C K Chang; F Chu; Q Chu; S Daniel; E de Bree; M Deraco; L Dominguez-Parra; D Elias; R Flynn; J Foster; A Garofalo; F N Gilly; O Glehen; A Gomez-Portilla; L Gonzalez-Bayon; S Gonzalez-Moreno; M Goodman; V Gushchin; Nadar N Hanna; J Hartmann; L Harrison; R Hoefer; J Kane; D Kecmanovic; S Kelley; J Kuhn; J Lamont; Julie R Lange; B Li; B Loggie; H Mahteme; G Mann; R Martin; R A Misih; B Moran; D Morris; L Onate-Ocana; N Petrelli; G Philippe; J Pingpank; A Pitroff; P Piso; M Quinones; L Riley; L Rutstein; S Saha; S Alrawi; A Sardi; schlomo schneebaum; P Shen; D Shibata; J Spellman; A Stojadinovic; J Stewart; J Torres-Melero; T Tuttle; V Verwaal; J Villar; N Wilkinson; R Younan; H Zeh; F Zoetmulder; G Sebbag
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.
Annals of surgical oncology 2007;14(1):128-33.
2006: Mohammed Mohiuddin; Kathryn Winter; Edith Mitchell; Nadar N Hanna; Albert Yuen; Charles Nichols; Robert Shane; Cherie Hayostek; Christopher Willett
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):650-5.
2006: Reza F Saidi; Stephen G ReMine; Paul S Dudrick; Nadar N Hanna
Is there a role for palliative gastrectomy in patients with stage IV gastric cancer?
World journal of surgery 2006;30(1):21-7.
2005: Joseph Gaugler; Nadar N Hanna; Jeanette A Linder; Charles W Given; Valerie Tolbert; Ritesh Kataria; William F Regine
Cancer caregiving and subjective stress: a multi-site, multi-dimensional analysis.
Psycho-oncology 2005;14(9):771-85.
2004: Arno J Mundt; Srinivasan Vijayakumar; John Nemunaitis; Alan B Sandler; Herbert Schwartz; Nadar N Hanna; Terrance D Peabody; Neil Senzer; Karen Chu; Camilla S Rasmussen; Paul D Kessler; Henrik S Rasmussen; Michael A Warso; Donald Kufe; Tapas Das Gupta; Ralph R Weichselbaum
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5747-53.
2004: Nadar N Hanna
Radiofrequency ablation of primary and metastatic hepatic malignancies.
Clinical colorectal cancer 2004;4(2):92-100.
2004: Neil Senzer; Sridhar Mani; Alexander Rosemurgy; John Nemunaitis; Casey Cunningham; Chandan Guha; Natalia Bayol; Michelle Gillen; Karen Chu; Camilla Rasmussen; Henrik Rasmussen; Donald Kufe; Ralph Weichselbaum; Nadar N Hanna
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):592-601.
2004: Nadar N Hanna; Alfred M Cohen
Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy.
Clinical colorectal cancer 2004;3(4):215-22.
2003: Nadar N Hanna; Robert M Mentzer
Molecular genetics and management strategies in hereditary cancer syndromes.
The Journal of the Kentucky Medical Association 2003;101(3):100-7.
2003: Rabih M Salloum; Mark P Saunders; Helena J Mauceri; Nadar N Hanna; David Henry Gorski; Mitchell C Posner; Ian J Stratford; Ralph R Weichselbaum
Dual induction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay.
The American surgeon 2003;69(1):24-7.
2002: Nadar N Hanna; Jose G Guillem; Amy Fox; Eric Steckelman; Bruce D Minsky; Alfred M Cohen
Intraoperative parasympathetic nerve stimulation with tumescence monitoring during total mesorectal excision for rectal cancer.
Journal of the American College of Surgeons 2002;195(4):506-12.
2002: Mohammed Mohiuddin; Mahesh Kudrimoti; William F Regine; Patrick C McGrath; Nadar N Hanna; William John
Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
Cancer journal (Sudbury, Mass.) 2002;8(3):255-62.
2001: Anand K Sharma; Sridhar Mani; Nadar N Hanna; Chandan Guha; B Vikram; R R Weichselbaum; Joseph A Sparano; B Sood; David Lee; William F Regine; M Muhodin; Joseph Valentino; JOSEPH HERMAN; Philip Desimone; S Arnold; J Carrico; Anna Rockich; J Warner-Carpenter; M Barton-Baxter
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
Human gene therapy 2001;12(9):1109-31.
2000: Mohammed Mohiuddin; M Hayne; William F Regine; Nadar N Hanna; PF Hagihara; P McGrath; G M Marks
Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.
International journal of radiation oncology, biology, physics 2000;48(4):1075-80.
2000: Nadar N Hanna; Saraswathy Seetharam; Helena J Mauceri; Michael A Beckett; Nora T Jaskowiak; Rabih M Salloum; DM Hari; Mohanraj Dhanabal; Ramani Ramchandran; Raghu Kalluri; Vikas P Sukhatme; Donald Kufe; Ralph R Weichselbaum
Antitumor interaction of short-course endostatin and ionizing radiation.
Cancer journal (Sudbury, Mass.) 2000;6(5):287-93.
2000: Nadar N Hanna; Daniel Kenady
Advances in the management of adrenal tumors.
Current opinion in oncology 2000;12(1):49-53.
1999: Nadar N Hanna; Daniel Kenady
Hypertension in patients with pheochromocytoma.
Current hypertension reports 1999;1(6):540-5.
1999: Helena J Mauceri; Nadar N Hanna; MJ Staba; Michael A Beckett; Donald Kufe; Ralph R Weichselbaum
Radiation-inducible gene therapy.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1999;322(2-3):225-8.
1999: Nadar N Hanna; Patrick C McGrath; David A Sloan; Daniel Kenady
Advances in the pathogenesis and treatment of thyroid cancer.
Current opinion in oncology 1999;11(1):42-7.
1998: Helena J Mauceri; Nadar N Hanna; Michael A Beckett; David Henry Gorski; MJ Staba; K A Stellato; K Bigelow; Ruth Heimann; Stephen Gately; Mohanraj Dhanabal; Gerald A Soff; Vikas P Sukhatme; Donald Kufe; Ralph R Weichselbaum
Combined effects of angiostatin and ionizing radiation in antitumour therapy.
Nature 1998;394(6690):287-91.
1997: Nadar N Hanna; Helena J Mauceri; J D Wayne; Dennis E Hallahan; Donald Kufe; Ralph R Weichselbaum
Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Cancer research 1997;57(19):4205-9.
1996: Helena J Mauceri; Nadar N Hanna; J D Wayne; Dennis E Hallahan; Samuel Hellman; Ralph R Weichselbaum
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.
Cancer research 1996;56(19):4311-4.
1996: Nadar N Hanna; K O'Donnell; G R Wolfe
Alveolar soft part sarcoma metastatic to the breast.
Journal of surgical oncology 1996;61(2):159-62.
1995: Dennis E Hallahan; Helena J Mauceri; L P Seung; E J Dunphy; J D Wayne; Nadar N Hanna; A Toledano; Samuel Hellman; Donald Kufe; Ralph R Weichselbaum
Spatial and temporal control of gene therapy using ionizing radiation.
Nature medicine 1995;1(8):786-91.
1987: R C Rees; B J Dalton; J F Young; Nadar N Hanna; G Poste
Augmentation of human natural killer cell activity by influenza virus antigens produced in Escherichia coli.
Journal of biological response modifiers 1987;6(1):69-87.
1982: Nadar N Hanna
Role of natural killer cells in control of cancer metastasis.
Cancer metastasis reviews 1982;1(1):45-64.
1981: Nadar N Hanna; I J Fidler
Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice.
Cancer research 1981;41(2):438-44.